Which has the lower trailing P/E, CHE or MMSI?

CHE has the lower trailing P/E: CHE trades at 26.12 and MMSI at 37.00. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CHE or MMSI?

Over the past five years, MMSI grew revenue faster — CHE at a 4.12% CAGR versus MMSI at 8.90%.

Does CHE or MMSI pay a bigger dividend?

CHE pays a dividend (0.48% yield), while MMSI has no payments in the available dividend history.

Is CHE or MMSI more profitable?

CHE runs the higher net margin — CHE at 10.60% versus MMSI at 9.22%.

How have CHE and MMSI total returns compared?

Over the past 10 years, CHE delivered 15.15% and MMSI delivered 14.28% annualized total return. Past performance doesn't predict future results.

Chemed Corporation (CHE) vs Merit Medical Systems, Inc. (MMSI)

A side-by-side comparison of Chemed Corporation and Merit Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

CHE

Chemed Corporation

$6.80B

$520.27HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

MMSI

Merit Medical Systems, Inc.

$5.35B

$89.54HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — CHE vs MMSI

growth of $100 · dividends reinvested · last 10y

CHE +289.8% (+14.6%/yr)MMSI +261.8% (+13.7%/yr)CHE compounded faster over this window

CHE MMSI

CHE vs MMSI: by the numbers

•CHE is the larger company ($6.80B vs $5.35B market cap).
•CHE trades at the lower trailing earnings multiple (26.12 vs 37.00 P/E), one valuation lens rather than an overall verdict.
•CHE converts more revenue to profit (10.60% vs 9.22% net margin).
•MMSI grew revenue faster over the past five years (8.90% vs 4.12% CAGR).
•CHE pays a dividend (0.48% yield), while MMSI has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CHE	MMSI
P/E ratio	26.12	37.00
Forward P/E	20.38	20.81
P/S ratio	2.69	3.40
P/B ratio	8.41	3.20
EV / EBITDA	17.50	17.03
FCF yield	4.63%	3.79%

Profitability

Metric	CHE	MMSI
Gross margin	30.44%	49.52%
Operating margin	13.46%	12.75%
Net margin	10.60%	9.22%
ROE	33.11%	8.67%
ROIC	19.48%	5.80%

Dividends

Metric	CHE	MMSI
Dividend yield	0.48%	N/A
Payout ratio	13.57%	N/A

Growth (annualized)

Metric	CHE	MMSI
Revenue CAGR (5Y)	4.12%	8.90%
EPS CAGR (5Y)	-1.65%	67.27%
FCF CAGR (5Y)	-5.44%	8.96%
Total return CAGR (5Y)	2.27%	4.55%

Frequently asked

Which has the lower trailing P/E, CHE or MMSI?: CHE has the lower trailing P/E: CHE trades at 26.12 and MMSI at 37.00. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CHE or MMSI?: Over the past five years, MMSI grew revenue faster — CHE at a 4.12% CAGR versus MMSI at 8.90%.
Does CHE or MMSI pay a bigger dividend?: CHE pays a dividend (0.48% yield), while MMSI has no payments in the available dividend history.
Is CHE or MMSI more profitable?: CHE runs the higher net margin — CHE at 10.60% versus MMSI at 9.22%.
How have CHE and MMSI total returns compared?: Over the past 10 years, CHE delivered 15.15% and MMSI delivered 14.28% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CHE analysis Full MMSI analysis Interactive comparison tool

Dig into the metrics

Chemed P/E ratio Merit Medical Systems P/E ratio Chemed dividend yield Chemed ROE Merit Medical Systems ROE Chemed operating margin Merit Medical Systems operating margin Chemed revenue growth Merit Medical Systems revenue growth Chemed free cash flow Merit Medical Systems free cash flow

Chemed & Merit Medical Systems appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.